SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEALTHSOURCE NYSE: (HS) UPWARD BOUND???
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward Collins who wrote (18)3/1/1997 12:26:00 AM
From: Linda Kaplan   of 25
 
They have set the price of the shares of this stock by agreeing to buy the shares at a price of 21.75. The HS management has signed the agreement, and will send the agreement to shareholders for approval. Cigna has to also get approval from 15 states authorities to okay the deal. After that, all our shares will be bought for 21.75 and there will be no brokerage fee or commission. Unless the deal falls through or is expected to fall through, the shares won't drop much from here and will not go up to the 21.75 sale price till near the date of the culmination of the deal. That date could be 6 months away. Because of the time premium, the shares won't go to 21.75 now or higher than that now, but also won't drop much. As it gets closer to the time of the deal the shares will rise to near the price of the deal. That's how it works. Since this deal is now public everyone knows what I just told you and this would effect the call options.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News